CLINICAL RESEARCH
Ischemia-Modified Albumin in Relation to Exercise Stress Testing
Eftihia Sbarouni, MD*,
Panagiota Georgiadou, MD,
George N. Theodorakis, MD and
Dimitrios Th. Kremastinos, MD
2nd Department of Cardiology, Onassis Cardiac Surgery Center, Athens, Greece
Manuscript received February 14, 2006;
revised manuscript received September 7, 2006,
accepted September 7, 2006.
* Reprint requests and correspondence: Dr. Eftihia Sbarouni, Onassis Cardiac Surgery Center, 2nd Department of Cardiology, 356 Syngrou Avenue, 17674 Athens, Greece (Email: elbee{at}ath.forthnet.gr).
OBJECTIVES: We examined whether ischemia-modified albumin (IMA) plasma levels change during exercise stress testing (EST) in patients with known coronary artery disease and whether the induced changes differ between positive and negative exercise tests.
BACKGROUND: Ischemia modified albumin is considered a marker of myocardial ischemia and increases after coronary angioplasty and in acute coronary syndromes.
METHODS: We studied 40 consecutive patients with established coronary artery disease who underwent EST. Venous samples, for IMA measurement, were collected before the stress test (baseline), at peak exercise, and 60 min after the completion of the exercise test.
RESULTS: There was significant difference in the IMA values at the 3 prespecified time points (p = 0.012), whereas there was no interaction between the IMA changes and the result of the stress test, whether positive or negative (p for the interaction term = 0.94). Baseline, peak EST, and post-EST IMA levels were similar in patients with positive and negative exercise tests (p = 0.61). The IMA significantly decreased at peak exercise compared with baseline values in positive (p < 0.0001) and in negative EST (p = 0.012). Moreover, IMA concentration increased 60 min after EST compared with peak-EST values in positive (p < 0.0001) and in negative tests (p = 0.003), returning to pre-EST levels in both groups.
CONCLUSIONS: The IMA plasma levels change significantly during exercise testing in patients with coronary artery disease, but there is no difference between positive and negative stress tests; this possibly implies that the observed changes do not reflect myocardial ischemia.
|
Abbreviations and Acronyms
| | EST = exercise stress test | | IMA = ischemia-modified albumin | | PCI = percutaneous coronary intervention |
|
This article has been cited by other articles:

|
 |

|
 |
 
T. H. Marwick, V. Dilsizian, and J. Narula
Ischemic Episode and Hanging on to a Painful Memory...
J. Am. Coll. Cardiol. Img.,
January 1, 2012;
5(1):
126 - 128.
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
P O Collinson and D C Gaze
Ischaemia-modified albumin: clinical utility and pitfalls in measurement
J. Clin. Pathol.,
September 1, 2008;
61(9):
1025 - 1028.
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A Gunduz, A Mentese, S Turedi, S C Karahan, U Mentese, O Eroglu, S Turkmen, I Turan, U Ucar, R Russell, et al.
Serum ischaemia-modified albumin increases in critical lower limb ischaemia
Emerg. Med. J.,
June 1, 2008;
25(6):
351 - 353.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
E. Sbarouni, P. Georgiadou, G. N. Theodorakis, and D. Th. Kremastinos
Reply
J. Am. Coll. Cardiol.,
June 19, 2007;
49(24):
2376 - 2377.
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
N. Kalay, Y. Cetinkaya, and I. Ozdogru
Ischemia-Modified Albumin and Myocardial Ischemia
J. Am. Coll. Cardiol.,
June 19, 2007;
49(24):
2375 - 2375.
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
D. Roy and J. C. Kaski
Ischemia-Modified Albumin: The Importance of Oxidative Stress
J. Am. Coll. Cardiol.,
June 19, 2007;
49(24):
2375 - 2376.
[Full Text]
[PDF]
|
 |
|
|